Translated material
The drug for therapy was added to the list of vital
The drug "spinraz" for the treatment of patients with spinal muscle atrophy (SMA) was introduced into the list of vital drugs. The corresponding order was signed by the Prime Minister of the Russian Federation Mikhail Mishustin, writes New Gazeta.
In total, 25 new names were included in the list. The order comes into force on January 1. From 2021, the treatment of children with the SMA will be funded by increasing personal income tax to 15 percent for people with an annual income of more than 5 million rubles.
Prior to the list of the purchase of Spinraza, it was assigned to the regions. At the same time, local officials in most cases refused to purchase it, citing a lack of money in the budget. One injection costs about 8 million rubles.
- You can support the patient’s life with a diagnosis of smears in two ways. Introduce one injection of the most expensive drug in the world of Zolgensma, the cost of which exceeds two million dollars. The drug is effective only for children under the age of two years, and it is not registered in Russia. The second path is annually and until the end of life as therapy to use the drug "Spinraz". Both drugs are considered equally effective.